ARV Super2

Theratechnologies’ Trogarzo® Approved by FDA for 30-Second Intravenous (IV) Push, Simplifying HIV Treatment for Heavily Treatment-Experienced Population

Retrieved on: 
Monday, October 3, 2022

The evolution of Trogarzo administration from intravenous infusion to intravenous push means less preparation and treatment time in clinics for patients and their health care providers, possibly allowing for more clinics to administer this treatment.

Key Points: 
  • The evolution of Trogarzo administration from intravenous infusion to intravenous push means less preparation and treatment time in clinics for patients and their health care providers, possibly allowing for more clinics to administer this treatment.
  • We are proud of our long-term commitment to bring much needed non-oral innovations to help shift the treatment paradigm for heavily treatment-experienced people living with HIV.
  • Results show that the safety and PK profile of Trogarzo administered via IV push are similar to that of IV infusion administration.
  • Do not receive Trogarzo if you have had an allergic reaction to Trogarzo or any of the ingredients in Trogarzo.

CODE (RED) Lights Up Giving Tuesday & World AIDS Day

Retrieved on: 
Wednesday, December 1, 2021

(RED) partners and supporters across gaming, retail, financial services and more will join forces as part of CODE (RED) .

Key Points: 
  • (RED) partners and supporters across gaming, retail, financial services and more will join forces as part of CODE (RED) .
  • "This World AIDS Day, (RED) is fighting two pandemics at once and making it easy for everyone to get involved by giving, gaming or gifting.
  • "As long as COVID continues to wreak havoc on the world's poorest and most vulnerable, we cannot end the fight against other pandemics like AIDS.
  • The lens is generously supported by Merck (known as MSD outside the U.S. and Canada) and will be available on World AIDS Day (December 1st).